The ESETT Trial: 2nd Line Medications in Status Epilepticus

Background: Dealing with a patient in status epilepticus, refractory to treatment with benzodiazepines, can be a sphincter tightening ordeal.  While most seizure activity responds to … Continue reading The ESETT Trial: 2nd Line Medications in Status Epilepticus